InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
7
Disclosed sells
0
T+90 hit rate
40%
T+90 mean return
-12.4%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Toledano Miranda Jayne, Director. Insider active across 4 companies, notably Compass Therapeutics, Inc.. Aggregated, 14 filings have been published. Split: 7 buys · 0 sell. Total volume traded: €120k. History available since 27 December 2021. The latest transaction was disclosed on 31 July 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations14 total
124,121 shares0Ordinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-24-002391:0
9,728 shares0Common Stock, $0.0001 par valueSEC:0001104659-24-078970:0
23,952 shares@ US$0.7115.1% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-003971:0
Ideal exit: 17 Sept 2024 (T+270)
27,472 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-23-083831:0
30,000 shares@ US$1.0127.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-23-001348:0
Ideal exit: 30 Dec 2023 (T+270)
50,000 shares@ US$0.531725.5% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-003988:0
Ideal exit: 8 Aug 2023 (T+270)
14,245 shares0Common Stock, par value $0.0001 per shareSEC:0001104659-22-082287:0
30,000 shares0COMMON STOCKSEC:0001104659-22-042282:0
6,800 shares@ US$2.78990.027% mcap50.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000165:0
Ideal exit: 11 Oct 2022 (T+270)
6,800 shares@ US$2.789916.2% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000165
Ideal exit: 11 Oct 2022 (T+270)
1,819 shares@ US$5.4950.0% of flowCommon StockSEC:0001104659-22-000437
Ideal exit: 23 Sept 2022 (T+270)
1,819 shares@ US$5.4950.0% of flowCommon StockSEC:0001104659-22-000437:0
Ideal exit: 23 Sept 2022 (T+270)
1,791,549 sharesCommon Stock, $.0001 Par ValueSEC:0001686530-21-000006
1,791,549 sharesCommon Stock, $.0001 Par ValueSEC:0001686530-21-000006:0
14 of 14 declarations
About Toledano Miranda Jayne
Toledano Miranda Jayne is a Board Member of Compass Therapeutics, Inc., NEXGEL, INC., and Entera Bio Ltd. With experience in the biotechnology and healthcare sector, she contributes to the governance and development strategy of the companies. Miranda is recognized for her expertise in innovation and risk management.
